Systemic anticancer therapy (SACT)
- Immunotherapy induced toxicity: Guidelines for Management of Immunotherapy Toxicity: (Including but not exclusive to: Ipilimumab, Nivolumab and Pembrolizumab and Atezolizumab).
- SACT (systemic anticancer therapy) induced toxicities: Systemic Anticancer Therapy Documentation page on the intranet.
- Bisphosphonates and osteonecrosis of the jaw: Scottish Dental Clinical Effectiveness Programme: Oral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw
- Mouth care guidance and support in cancer and palliative care